腹腔镜与开腹肝段/双段切除术治疗肝细胞癌的倾向性评分匹配分析
该回顾性研究纳入2018至2023年接受肝段或双段切除术的112例肝细胞癌患者,其中腹腔镜组49例、开腹组63例,经倾向性评分匹配后比较短期与长期结局。结果显示腹腔镜组出血量更少、住院时间更短、严重并发症及感染发生率更低,而5年总生存率与无复发生存率两组无显著差异。
要点
- 腹腔镜肝段/双段切除术治疗肝细胞癌安全可行,短期结局优于开腹手术。
- 匹配后腹腔镜组出血量、住院时间、严重并发症及感染率均更低。
- 两组5年总生存率与无复发生存率无显著差异。
核心结论
- 腹腔镜肝段及双段切除术治疗肝细胞癌可行且安全,短期结局优于开腹手术,长期结局相似。
研究设计与样本
- 回顾性分析2018至2023年接受肝段或双段切除术的112例肝细胞癌患者,其中腹腔镜组49例(43.8%)、开腹组63例(56.2%),采用倾向性评分匹配比较短期与长期结局。
主要发现
- 匹配前腹腔镜组较开腹组出血量更低(307 vs. 844 mL,p < 0.001)、住院时间更短(15 vs. 20天,p = 0.010)、严重术后并发症率更低(14% vs. 33%,p = 0.032)、总体感染率更低(20% vs. 40%,p = 0.029)、器官/腔隙手术部位感染率更低(10% vs. 30%,p = 0.011)。
- 匹配后腹腔镜组上述指标仍优于开腹组:出血量323 vs. 762 mL、住院时间15 vs. 22天、严重并发症17% vs. 39%、总体感染19% vs. 47%、器官/腔隙手术部位感染11% vs. 36%。
- 腹腔镜组术后C反应蛋白水平更低(p = 0.006)、凝血酶原时间更长(p = 0.012)、胆碱酯酶水平更高(p = 0.046)。
- 两组5年总生存率(57.1% vs. 46.7%,p = 0.685)与无复发生存率(34.9% vs. 26.8%,p = 0.475)差异无统计学意义。
临床怎么用
- 对于适合行肝段或双段切除术的肝细胞癌患者,腹腔镜入路可减少出血、缩短住院时间并降低严重并发症及感染风险。
- 腹腔镜肝段/双段切除术不损害长期肿瘤学结局,可作为开腹手术的替代选择。
局限性
- 本研究为单中心回顾性分析,样本量有限(112例),结论需前瞻性研究进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study aimed to compare short- and long-term outcomes of laparoscopic hepatectomy (LH) versus open hepatectomy (OH) in patients with HCC who underwent sectionectomies or bisectionectomies. METHODS: From 2018 to 2023, HCC patients who underwent a sectionectomy or bisectionectomy were retrospectively analyzed. Propensity score matching (PSM) was used to assess the association of operative approaches with short- and long-term outcomes. RESULTS: Among 112 patients with HCC, 49 (43.8%) and 63 (56.2%) underwent LH and OH, respectively. Compared with OH, LH was respectively associated with lower blood loss (844 vs. 307 mL, p < 0.001), shorter hospital stay (20 vs. 15 days, p = 0.010), lower rates of severe postoperative complications (33% vs. 14%, p = 0.032) and overall infections (40% vs. 20%, p = 0.029), and organ/space surgical site infections (30% vs. 10%, p = 0.011). After PSM, LH remained superior regarding blood loss, hospital stay, severe postoperative complications, overall infections, and organ/space SSIs (323 mL, 15 days, 17, 19, and 11% vs. 762 mL, 22 days, 39, 47, and 36%, respectively). The patients undergoing LH had lower C-reactive protein (CRP) levels (p = 0.006), longer prothrombin time (p = 0.012), and higher cholinesterase levels (p = 0.046) than the patients undergoing OH throughout the postoperative period. The differences between the 5-year OS (57.1% vs. 46.7%, p = 0.685) and RFS (34.9% vs. 26.8%, p = 0.475) rates of the respective LH and OH patients were not significant. CONCLUSIONS: Laparoscopic sectionectomies and bisectionectomies for patients with HCC are feasible and safe, with better short-term outcomes than open sectionectomies and bisectionectomies, and provide similar long-term outcomes.
引用
- Lai TT, Matsui K, Kosaka H, et al. Laparoscopic versus open sectionectomy and bisectionectomy for hepatocellular carcinoma: a propensity score-matched analysis of short- and long-term outcomes. Surg Endosc. 2026. PMID: 42587043. doi:10.1007/s00464-026-12978-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。